Single-photon emission computed tomography (SPECT) is a growing nuclear medicine imaging technique high adopted in applications such as oncology, neurology, cardiology, and infectious diseases. Standalone SPECT systems contribute the highest revenue in the market as they are one of the oldest imaging modalities available in the market. However, due to the advent of hybrid SPECT systems, the growth rate of standalone SPECT systems is expected to be moderate during the forecast period.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by application

Cardiology

Oncology

General imaging

Neurology

PART 07: Market segmentation by product

Standalone SPECT

Hybrid SPECT

PART 08: Market segmentation by end-user

Hospitals

Diagnostic centers and clinics

Academic and research centers

PART 09: Geographical segmentation

SPECT market in the Americas

SPECT market in EMEA

SPECT market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

Market drivers

Impact of drivers on key customer segments

Market challenges

Impact of challenges on key customer segments

PART 12: Market trends

Growing focus on development of PET/MR hybrid

imaging systems

Growing research activities to widen the applications of

hybrid imaging

Growing focus on emerging economies

PART 13: Vendor landscape

Competitive landscape analysis

PART 14: Key vendor analysis

GE Healthcare

Philips Healthcare

Siemens Healthineers

Key company to watch

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio